Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Feasibility Study to Evaluate the Safety of Photochemical Tissue Passivation (PTP) Treatment of Saphenous Vein Grafts in Participants Undergoing Elective CABG

NCT06150872 is registered in ClinicalTrials.gov with DurVena, Inc. as lead sponsor.

NCT NCT06150872
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06150872 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Feasibility Study to Evaluate the Safety of Photochemical Tissue Passivation (PTP) Treatment of Saphenous Vein Grafts in Participants Undergoing Elective CABG
Lead sponsor
DurVena, Inc.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
January 8, 2024
Completion date
March 30, 2025
Enrollment
4 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease